A Study of DR-0201 in Subjects With Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Conditions: B-cell Non Hodgkin Lymphoma Interventions: Drug: DR-0201 Sponsors: Dren Bio; Novotech (Australia) Pty Limited Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials